Cargando…

Evaluation of mass drug administration in the program to control imported lymphatic filariasis in Thailand

BACKGROUND: Migration plays a major role in the emergence and resurgence of lymphatic filariasis (LF) in many countries. Because of the high prevalence of Imported Bancroftian Filariasis (IBF) caused by nocturnally periodic Wuchereria bancrofti and the intensive movement of immigrant workers from en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toothong, Tanaporn, Tipayamongkholgul, Mathuros, Suwannapong, Nawarat, Suvannadabba, Saravudh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587715/ https://www.ncbi.nlm.nih.gov/pubmed/26415693 http://dx.doi.org/10.1186/s12889-015-2325-x

Ejemplares similares

How Thailand eliminated lymphatic filariasis as a public health problem
por: Rojanapanus, Sunsanee, et al.
Publicado: (2019)

Correction to: How Thailand eliminated lymphatic filariasis as a public health problem
por: Rojanapanus, Sunsanee, et al.
Publicado: (2019)

Matters of Gender and Social Disparities Regarding Postnatal Care Use Among Nepalese Women: A Cross-Sectional Study in Morang District
por: Amatya, Rakchya, et al.
Publicado: (2023)

Effects of psychosocial factors on nonadherence to ART in Ganta, Nimba county, Liberia
por: Strother, Philomena J., et al.
Publicado: (2022)

Intention to Extend Working Life among Thai Registered Nurses in Ministry of Public Health: A National Survey
por: Sirisub, Pooncharat, et al.
Publicado: (2019)

The Health and Economic Burdens of Lymphatic Filariasis Prior to Mass Drug Administration Programs
por: Mathew, Christopher G, et al.
Publicado: (2020)

National Mass Drug Administration Costs for Lymphatic Filariasis Elimination
por: Goldman, Ann S., et al.
Publicado: (2007)

Elimination of lymphatic filariasis: current perspectives on mass drug administration
por: Gyapong, John O, et al.
Publicado: (2018)

Impact of mass drug administration for elimination of lymphatic filariasis in Nepal
por: Ojha, Chet Raj, et al.
Publicado: (2017)

Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia
por: Bhullar, Navneet, et al.
Publicado: (2010)

Factors determining noncompliance to mass drug administration for lymphatic filariasis elimination
por: Nujum, Zinia T, et al.
Publicado: (2012)

Increasing Compliance with Mass Drug Administration Programs for Lymphatic Filariasis in India through Education and Lymphedema Management Programs
por: Cantey, Paul T., et al.
Publicado: (2010)

Mass Drug Administration Coverage Evaluation Survey for Lymphatic Filariasis in Bagalkot and Gulbarga Districts
por: Patel, Prakash Kurubarahalli
Publicado: (2012)

Cessation of Mass Drug Administration for Lymphatic Filariasis in Zanzibar in 2006: Was Transmission Interrupted?
por: Rebollo, Maria P., et al.
Publicado: (2015)

Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis
por: Alshehri, Abdullah, et al.
Publicado: (2023)

Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis
por: Stolk, Wilma A., et al.
Publicado: (2013)

WILL MASS DRUG ADMINISTRATION ELIMINATE LYMPHATIC FILARIASIS? EVIDENCE FROM NORTHERN COASTAL TANZANIA
por: PARKER, MELISSA, et al.
Publicado: (2013)

Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination
por: Alexander, Neal D. E.
Publicado: (2015)

Endpoints for Lymphatic Filariasis Programs
por: Grady, Caroline A., et al.
Publicado: (2007)

Reduction in Acute Filariasis Morbidity during a Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea
por: Tisch, Daniel J., et al.
Publicado: (2011)

An Evaluation of Coverage and Compliance of Mass Drug Administration 2006 for Elimination of Lymphatic Filariasis in Endemic Areas of Gujarat
por: Kumar, Pradeep, et al.
Publicado: (2008)

Epidemiological Assessment of Eight Rounds of Mass Drug Administration for Lymphatic Filariasis in India: Implications for Monitoring and Evaluation
por: Swaminathan, Subramanian, et al.
Publicado: (2012)

Simulating the effect of evaluation unit size on eligibility to stop mass drug administration for lymphatic filariasis in Haiti
por: Kostandova, Natalya, et al.
Publicado: (2022)

Maintaining effective mass drug administration for lymphatic filariasis through in-process monitoring in Sierra Leone
por: Hodges, Mary H, et al.
Publicado: (2012)

A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
por: Krentel, Alison, et al.
Publicado: (2013)

The Role of Personal Opinions and Experiences in Compliance with Mass Drug Administration for Lymphatic Filariasis Elimination in Kenya
por: Njomo, Doris W., et al.
Publicado: (2012)

Elimination of Lymphatic Filariasis: Mass Drug Administration in Endemic Areas of (Bidar District) Karnataka-2008
por: Ranganath, TS, et al.
Publicado: (2012)

COMMUNITY MEMBERS' PERCEPTIONS OF MASS DRUG ADMINISTRATION FOR CONTROL OF LYMPHATIC FILARIASIS IN RURAL AND URBAN TANZANIA
por: KISOKA, WILLIAM J., et al.
Publicado: (2016)

Seroprevalence and Spatial Epidemiology of Lymphatic Filariasis in American Samoa after Successful Mass Drug Administration
por: Lau, Colleen L., et al.
Publicado: (2014)

Mass Drug Administration for the Elimination of Lymphatic Filariasis — Port-au-Prince, Haiti, 2011–2012
por: Streit, Thomas, et al.
Publicado: (2013)

The role of gender relations in uptake of mass drug administration for lymphatic filariasis in Alor District, Indonesia
por: Krentel, Alison, et al.
Publicado: (2018)

Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria
por: Pam, Dung D., et al.
Publicado: (2017)

Improved assessment of mass drug administration and health district management performance to eliminate lymphatic filariasis
por: Maroto-Camino, Carmen, et al.
Publicado: (2019)

Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya
por: Njenga, Sammy M., et al.
Publicado: (2017)

Prevalence and risk factors associated with lymphatic filariasis in American Samoa after mass drug administration
por: Coutts, Shaun P., et al.
Publicado: (2017)

Knowledge, attitudes and perceptions regarding lymphatic filariasis: study on systematic noncompliance with mass drug administration
por: Cabral, Silvia, et al.
Publicado: (2017)

Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar
por: Dickson, Benjamin F. R., et al.
Publicado: (2021)

Assessing factors influencing communities’ acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana
por: Niles, Reza A., et al.
Publicado: (2021)

What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling Up Mass Drug Administration Programs
por: Kastner, Randee J., et al.
Publicado: (2015)

Epidemiological and Entomological Evaluations after Six Years or More of Mass Drug Administration for Lymphatic Filariasis Elimination in Nigeria
por: Richards, Frank O., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2j3rqepack98ak1868s2krh14k